RASTRELLI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.041
EU - Europa 5.176
AS - Asia 1.362
OC - Oceania 104
AF - Africa 42
SA - Sud America 9
Totale 16.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.019
RU - Federazione Russa 1.924
PL - Polonia 986
IT - Italia 786
IE - Irlanda 596
SE - Svezia 381
HK - Hong Kong 354
SG - Singapore 349
CN - Cina 305
FI - Finlandia 130
IN - India 127
AU - Australia 104
GB - Regno Unito 101
DE - Germania 68
JO - Giordania 67
ID - Indonesia 55
CH - Svizzera 49
TR - Turchia 45
NL - Olanda 36
VN - Vietnam 35
CI - Costa d'Avorio 33
ES - Italia 33
UA - Ucraina 23
CA - Canada 21
FR - Francia 18
AT - Austria 12
LT - Lituania 9
KR - Corea 7
PH - Filippine 6
RO - Romania 6
BR - Brasile 5
DK - Danimarca 5
TW - Taiwan 4
ZA - Sudafrica 4
AR - Argentina 2
BE - Belgio 2
IR - Iran 2
LK - Sri Lanka 2
PT - Portogallo 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
MX - Messico 1
PE - Perù 1
SY - Repubblica araba siriana 1
Totale 16.734
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.285
Fairfield 1.350
Warsaw 979
Ashburn 692
Woodbridge 612
Dublin 596
Seattle 568
Cambridge 546
Houston 511
Chandler 505
Wilmington 427
Lawrence 278
Altamura 276
Singapore 272
Hong Kong 226
Princeton 186
Ann Arbor 159
Moscow 152
Florence 142
Melbourne 102
Mumbai 102
Medford 100
Beijing 93
Boston 85
San Diego 82
Boardman 80
Milan 56
Jakarta 51
Shanghai 51
Bern 48
Buffalo 47
New York 46
Jacksonville 45
Falls Church 39
Abidjan 33
Dong Ket 30
Hillsboro 30
Rome 30
Barcelona 28
Izmir 28
London 28
Norwalk 27
Kent 25
Los Angeles 22
Helsinki 21
Dearborn 18
Lappeenranta 16
West Jordan 16
Redwood City 15
Yubileyny 15
Toronto 14
Andover 11
Chicago 11
Pune 11
Bologna 9
Guangzhou 9
North Salt Lake 9
Vienna 9
Bremen 8
Redmond 8
Barnet 7
Haarlem 7
Hefei 7
Marciano della Chiana 7
Shenzhen 7
Munich 6
Naples 6
Omaha 6
Verona 6
Nanjing 5
Parma 5
Phoenix 5
Prescot 5
Seoul 5
Tappahannock 5
Vilnius 5
Amsterdam 4
Bari 4
Cagliari 4
Cape Town 4
Cerreto Guidi 4
Figline Valdarno 4
Islington 4
Laurel 4
Siena 4
Southwark 4
Turin 4
Washington 4
Yreka 4
Ankara 3
Buting 3
Capelle aan den IJssel 3
Castelliri 3
Falkenstein 3
Frankfurt am Main 3
Fremont 3
Giussano 3
Iseo 3
Istanbul 3
Medan 3
Totale 12.449
Salva come PNG Salva come JPEG
Nome #
Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: A pharmacogenetic study 290
FATTORI DI RISCHIO CONVENZIONALI E NON CONVENZIONALI NEL SOGGETTO CON DISFUNZIONE ERETTILE 268
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 251
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 245
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlates with Sexual Dysfunctions 239
Semen cryopreservation for men banking for oligospermia, cancers, and other pathologies: prediction of post-thaw outcome using basal semen quality. 237
Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study 175
Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction 157
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 154
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 151
Insight on the intracrinology of menopause: androgen production within the human vagina 148
Chromatin Protamination and Catsper Expression in Spermatozoa Predict Clinical Outcomes after Assisted Reproduction Programs 138
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. 135
The pharmacotherapy of male hypogonadism besides androgens 133
Anti-inflammatory effects of androgens in the human vagina 132
Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies 131
Benign prostatic hyperplasia: a new metabolic disease? 129
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 128
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? 126
Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. 126
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction 125
Impaired masturbation-induced erections: a new cardiovascular risk factor for male subjects with sexual dysfunction. 125
Treatment of Functional Hypogonadism Besides Pharmacological Substitution 125
The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction. 124
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis 124
Testosterone Replacement Therapy and Cardiovascular Risk: A Review 124
Testosterone, cardiovascular disease and the metabolic syndrome. 123
Gynecomastia in subjects with sexual dysfunction 123
Associations between sex steroids and the development of metabolic syndrome: A longitudinal study in European men 121
Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction 121
First-generation phosphodiesterase type 5 inhibitors dropout: A comprehensive review and meta-analysis 120
Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer 118
Body Mass Index Regulates Hypogonadism-Associated CV Risk:Results from a Cohort of Subjects with Erectile Dysfunction. 117
An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study. 116
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis 114
Pulse Pressure Independently Predicts Major Cardiovascular Events in Younger But Not in Older Subjects with Erectile Dysfunction. 113
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. 113
How to define hypogonadism? Results from a population of men consulting for sexual dysfunction 113
Cardiovascular impact of testosterone therapy for hypogonadism. 113
Sexual function of the ageing male 112
Erectile dysfunction in fit and healthy young men: psychological or pathological? 112
Family History for Cardio-Metabolic Diseases: A Predictor of Major Adverse Cardiovascular Events in Men With Erectile Dysfunction 112
Low Testosterone Levels Predict Clinical Adverse Outcomes in SARS-CoV-2 Pneumonia Patients 112
Type 2 diabetes mellitus and testosterone: a meta-analysis study. 111
Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction. 111
Testosterone treatment and cardiovascular and venous thromboembolism risk: what is 'new'? 110
Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. 110
Treatment of premature ejaculation and comorbid endocrine and metabolic disorders 110
Clinical implications of measuring prolactin levels in males of infertile couples. 108
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer 107
Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study 107
Endocrine control of ejaculation 105
SIEDY Scale 3, a New Instrument to Detect Psychological Component in Subjects with Erectile Dysfunction. 105
Natural history, risk factors and clinical features of primary hypogonadism in ageing men: Longitudinal Data from the European Male Ageing Study 105
Serum PSA as a Predictor of Testosterone Deficiency. 104
Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. 103
Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry 103
Impact of Metabolically Healthy Obesity in Patients with Andrological Problems. 103
Effect of treatment with testosterone on endothelial function in hypogonadal men: a systematic review and meta-analysis 103
Clinical correlates of enlarged prostate size in subjects with sexual dysfunction. 103
Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. 103
An update on heart disease risk associated with testosterone boosting medications. 102
Characteristics of compensated hypogonadism in patients with sexual dysfunction 101
Testosterone and sexual function 101
Metabolically healthy and unhealthy obesity in erectile dysfunction and male infertility 100
Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: cross-sectional and longitudinal analyses. 100
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men 99
SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction 99
Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. 98
Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner's hypoactive sexual desire in comparison with conventional risk factors. 98
Sexual and Cardiovascular Correlates of Male Unfaithfulness. 97
Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study 97
High Triglycerides Predicts Arteriogenic Erectile Dysfunction and Major Adverse Cardiovascular Events in Subjects With Sexual Dysfunction 97
Relationship of Testis Size and LH Levels with Incidence of Major Adverse Cardiovascular Events in Older Men with Sexual Dysfunction. 97
Paediatric and adult-onset male hypogonadism 97
Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility. 96
Vascular and Chronological Age in Subjects with Erectile Dysfunction: A Cross-Sectional Study 96
Obesity and Aging in Late-Onset Hypogonadism 96
Testosterone and Metabolic Syndrome: A Meta-AnalysisStudy. 95
Emerging medication for the treatment of male hypogonadism. 95
Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. 95
The safety and efficacy of Avanafil, a new 2nd generation PDE5i: Comprehensive review and meta-analysis 95
Pharmacological management of late-onset hypogonadism 95
Testosterone deficiency in the aging male and its relationship with sexual dysfunction and cardiovascular diseases 95
Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective. 95
The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction. 95
Testosterone and sexual function in men. 95
How to recognize late-onset hypogonadism in men with sexual dysfunction. 93
Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men's Health? 93
The Role of Somatic Symptoms in Sexual Medicine: Somatization as Important Contextual Factor in Male Sexual Dysfunction 92
Erectile dysfunction and cardiovascular risk: a review of current findings. 92
Biochemical predictors of structural hypothalamus-pituitary abnormalities detected by magnetic resonance imaging in men with secondary hypogonadism. 92
The hormonal control of ejaculation. 91
The role of prolactin in andrology: what is new? 90
The Physician's Gender Influences the Results of the Diagnostic Workup for Erectile Dysfunction 90
SUBJECTIVE PERCEPTION OF EJACULATE VOLUME REFLECTS OBJECTIVE CHANGES IN EJACULATE VOLUME 90
Ipogonadismo maschile, sindrome metabolica e disfunzione erettile: dove comincia il bandolo della matassa. 90
Vascular and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study 90
Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). 90
Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study 89
Totale 11.832
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.394 0 0 0 0 0 0 326 325 317 187 173 66
2020/20211.477 136 133 61 200 55 191 67 93 172 172 111 86
2021/20221.248 49 149 130 48 49 59 44 125 71 48 142 334
2022/20232.761 279 663 88 176 171 461 359 125 230 46 73 90
2023/20241.307 49 116 210 68 92 140 61 280 46 113 70 62
2024/20255.570 331 790 447 1.061 2.250 689 2 0 0 0 0 0
Totale 17.073